Bausch Health Companies (BHC) Intangibles (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Intangibles came in at $4.2 billion in Q2 2026, down 17.2% year-over-year from $5.0 billion in Q2 2025, and down 5.11% quarter-over-quarter from $4.4 billion in Q1 2026.
Analysis
Bausch Health Companies (BHC) Intangibles (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Intangibles across 18 years of filings, most recently posting $4.2 billion for Q2 2026.
- In Q2 2026, Intangibles fell 17.2% year-over-year to $4.2 billion; the TTM figure through Jun 2026 stood at $4.2 billion (down 17.2% YoY), while the FY2025 annual figure was $4.6 billion, down 16.36% from the prior year.
- Intangibles came in at $4.2 billion for Q2 2026 at Bausch Health Companies, down from $4.4 billion in the prior quarter.
- In the past five years, Intangibles ranged from a high of $6.7 billion in Q3 2023 to a low of $4.2 billion in Q2 2026.
- Average Intangibles over 5 years is $5.6 billion, with a median of $5.6 billion recorded in 2023.
- Year-over-year, Intangibles climbed 11.69% in 2023 and declined 17.2% in 2026.
- Over 5 years, Intangibles stood at $5.8 billion in 2022, then increased by 11.31% to $6.5 billion in 2023, then fell by 14.02% to $5.6 billion in 2024, then decreased by 16.36% to $4.6 billion in 2025, then dropped by 9.99% to $4.2 billion in 2026.
- Per Business Quant data, the three most recent Intangibles figures were $4.2 billion in Q2 2026, $4.4 billion in Q1 2026, and $4.6 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 3.45 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 13.68 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 1.09 Bn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 587.83 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 4.18 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 142.48 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 449.86 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 29.23 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - | 5.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.18 Bn |
| Mar 31, 2026 | 4.40 Bn |
| Dec 31, 2025 | 4.64 Bn |
| Sep 30, 2025 | 4.83 Bn |
| Jun 30, 2025 | 5.05 Bn |
| Mar 31, 2025 | 5.30 Bn |
| Dec 31, 2024 | 5.55 Bn |
| Sep 30, 2024 | 5.65 Bn |
| Jun 30, 2024 | 5.90 Bn |
| Mar 31, 2024 | 6.18 Bn |
| Dec 31, 2023 | 6.46 Bn |
| Sep 30, 2023 | 6.73 Bn |
| Jun 30, 2023 | 5.30 Bn |
| Mar 31, 2023 | 5.55 Bn |
| Dec 31, 2022 | 5.80 Bn |
| Sep 30, 2022 | 6.02 Bn |
| Jun 30, 2022 | 6.32 Bn |
| Mar 31, 2022 | 6.63 Bn |
| Dec 31, 2021 | 6.95 Bn |
| Sep 30, 2021 | 7.26 Bn |